Logo
  • Chemistry
  • Pharma
  • Strategy
  • Innovation
  • Technology
  • Energy
  • Digitalization
  • Logistics
  • DE
  • EN
Logo
  • News
  • Topics
  • Books
  • Publication
  • Companies
  • Events
  • Jobs

most read article

BASF beabsichtigt Übernahme von Anteilen an Alsachimie
28.05.2025 • News

BASF beabsichtigt Übernahme von Anteilen an Alsachimie

BASF und DOMO Chemicals haben eine Vereinbarung unterzeichnet, die BASF das Recht gibt, den 49-prozentigen Anteil von DOMO Chemicals am Joint Venture Alsachimie zu übernehmen, an dem BASF derzeit 51% hält.

Empty Image
12.02.2016 • News

Akzo and BASF in Coatings Sale Talks

Statement: Thomas Dassler, CEO, Häffner
11.12.2024 • News • Strategy

Statement: Thomas Dassler, CEO, Häffner

CHEManager asked executives and industry experts from a broad range of chemical distributors to share their views on how their companies are dealing with this changing economic environment and the resulting opportunities and challenges.

CSDDD: The Formula for a Sustainable Chemical Industry?
11.12.2024 • News • Strategy

CSDDD: The Formula for a Sustainable Chemical Industry?

The EU's Corporate Sustainability Due Diligence Directive (CSDDD) is reshaping the chemical industry's approach to environmental and social responsibility. A close look at the requirements reveals significant changes to supply chain oversight, risk management, and sustainability reporting. Chemical companies must implement new strategies to ensure compliance, drive innovation, and adapt to evolving regulations.

Doppelganger Plastics: A More Desirable Alternative?
11.12.2024 • News • Strategy

Doppelganger Plastics: A More Desirable Alternative?

Plastics are highly effective but environmentally damaging. PET is a prime example, being cheap and recyclable yet oil-based. With plastics set to consume 20% of global oil and gas by 2050, sustainable alternatives are crucial. Enter PEF, a bioplastic that could revolutionize the industry. Can PEF be the solution we need?

Lilly to Expand US Drug Manufacturing with $27 Billion Investment
27.02.2025 • News

Lilly to Expand US Drug Manufacturing with $27 Billion Investment

Eli Lilly plans to invest $27 billion to bolster its domestic medicine production across several therapeutic areas by building four new manufacturing sites in the US.

Topics

  • Chemistry
  • Pharma
  • Strategy
  • Innovation
  • Technology
  • Energy
  • Digitalization
  • Logistics
  • Newsletter
  • Contact
  • About us
  • Media Kit
  • Imprint
  • Terms and Conditions
  • Data Protection
Wiley Branding
  • News
  • Topics
  • Books
  • Publication
  • Companies
  • Events
  • Jobs
  • Chemistry
  • Pharma
  • Strategy
  • Innovation
  • Technology
  • Energy
  • Digitalization
  • Logistics
    • DE
    • EN